Skip to main content
Back
Watch Compare

Gossamer Bio, Inc.

Data quality: 100%
GOSS
Nasdaq Manufacturing Chemicals
$0.37
▲ $0.03 (7.46%)
Mkt Cap: 87.61 M
Price
$0.37
Mkt Cap
87.61 M
Day Range
$0.34 — $0.38
52-Week Range
$0.32 — $3.87
Volume
6,106,899
Open $0.35
50D / 200D Avg
$1.21
69.12% below
50D / 200D Avg
$2.16
82.69% below

Quick Summary

Key Takeaways

Negative free cash flow of -171.35 M
Capital efficient — spends only 0.16% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-57.74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-80.76%
Net Margin-351.49%
Op. Margin-352.23%

Safety

Debt / Equity
N/A
Current Ratio3.28
Interest Coverage-15.54

Valuation

PE (TTM)
-0.51
Above sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -0.5 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % -351.5 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -57.74% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 48.47 M Net Income (TTM) -170.37 M
ROE N/A ROA -75.76%
Gross Margin N/A Operating Margin -352.23%
Net Margin -351.49% Free Cash Flow (TTM) -171.35 M
ROIC -80.76% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.28
Interest Coverage -15.54 Asset Turnover 0.22
Working Capital 141.87 M Tangible Book Value -82.33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.51 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1.81
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -195.57%
Market Cap 87.61 M Enterprise Value 78.68 M
Per Share
EPS (Diluted TTM) -0.75 Revenue / Share 0.21
FCF / Share -0.73 OCF / Share -0.73
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.16% FCF Conversion 100.57%
SBC-Adj. FCF -183.84 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 48.47 M 114.70 M — — —
Net Income -170.37 M -56.53 M -179.82 M -229.38 M -234.00 M
EPS (Diluted) -0.75 -0.25 -1.18 -2.71 -3.13
Gross Profit — — — — —
Operating Income -170.73 M -59.92 M -183.76 M -218.59 M -216.12 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 24,000.0 833,000.0 1.61 M 1.83 M 1.74 M
Interest Expense 10.99 M 11.52 M 13.51 M 13.88 M 19.44 M
Income Tax -88,000.0 893,000.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 172.25 M 315.29 M 311.92 M 272.45 M 343.66 M
Total Liabilities 295.01 M 285.80 M 249.15 M 260.37 M 222.19 M
Shareholders' Equity -122.76 M 29.49 M 62.77 M 12.08 M 121.46 M
Total Debt — 0.0 814,000.0 11.99 M 29.08 M
Cash & Equivalents 37.73 M 46.07 M 32.11 M 111.97 M 183.40 M
Current Assets 167.64 M 309.89 M 306.52 M 261.88 M 331.78 M
Current Liabilities 63.44 M 45.01 M 51.60 M 49.23 M 39.86 M